Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.72 USD | -3.50% | -5.37% | -49.02% |
08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.02% | 632M | |
+37.88% | 705B | |
+32.82% | 583B | |
-3.54% | 364B | |
+20.47% | 332B | |
+5.38% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.53% | 169B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Capital One Starts Coverage on EyePoint Pharmaceuticals with Overweight Rating, $44 Price Target